From July 1, 2022 to September 30, 2022, the company has repurchased 1,164,200 shares, representing 0.24% for CNY 10.12 million. With this, the company has completed the repurchase of 6,300,000 shares, representing 1.29% for CNY 59.99 million under the buyback announced on May 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.85 CNY | -2.36% | -9.77% | +6.51% |
25/04 | Guangdong VTR Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
25/04 | Guangdong VTR Bio-Tech Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+6.51% | 533M | |
+16.77% | 12.05B | |
+3.11% | 5.94B | |
+6.97% | 5.51B | |
+14.80% | 5.03B | |
-20.47% | 2.7B | |
+4.52% | 1.95B | |
-14.27% | 1.25B | |
-10.16% | 952M | |
-18.21% | 919M |
- Stock Market
- Equities
- 300381 Stock
- News Guangdong VTR Bio-Tech Co., Ltd.
- Tranche Update on Guangdong VTR Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 18, 2022.